In Silico Identification of Widely Used and Well Tolerated Drugs That May Inhibit SARSCov- 2 3c-Like Protease and Viral RNA-Dependent RNA Polymerase Activities, and May Have Potential to Be Directly Used in Clinical Trials
doi 10.26434/chemrxiv.12123204.v1
Full Text
Open PDFAbstract
Available in full text
Date
April 16, 2020
Authors
Publisher
American Chemical Society (ACS)